These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28618926)

  • 21. BR-MA, OM-MA, GI-MA and CEA: clinical evaluation using the IMMULITE analyzer.
    van Dalen A
    Tumour Biol; 1999; 20(3):117-29. PubMed ID: 10213919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Distler W
    Clin Chem Lab Med; 1998 Nov; 36(11):841-6. PubMed ID: 9877089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated CA125 in breast cancer--A sign of advanced disease.
    Norum LF; Erikstein B; Nustad K
    Tumour Biol; 2001; 22(4):223-8. PubMed ID: 11399947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
    Shao Y; Sun X; He Y; Liu C; Liu H
    PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S; Szmitkowski M; Wojtukiewicz M
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of blood markers for early breast cancer diagnosis.
    Bayo J; Castaño MA; Rivera F; Navarro F
    Clin Transl Oncol; 2018 Apr; 20(4):467-475. PubMed ID: 28808872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
    Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
    Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of tumor markers in southern Indian breast cancer patients.
    Porika M; Malotu N; Veldandi UK; Yadala N; Abbagani S
    Asian Pac J Cancer Prev; 2010; 11(1):157-9. PubMed ID: 20593949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of bone scintigraphy with serum tumor markers of CA 15-3 and carcinoembryonic antigen in patients with breast carcinoma.
    Gedik GK; Kiratli PO; Tascioglu B; Aras T
    Saudi Med J; 2006 Mar; 27(3):317-22. PubMed ID: 16532090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
    Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
    Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer-A retrospective analysis of kinetics on 743 breast cancer patients.
    Stieber P; Nagel D; Blankenburg I; Heinemann V; Untch M; Bauerfeind I; Di Gioia D
    Clin Chim Acta; 2015 Aug; 448():228-31. PubMed ID: 26160053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Breast Tumor Onset on Blood Count, Carcinoembryonic Antigen, Cancer Antigen 15-3 and Lymphoid Subpopulations Supported by Automatic Classification Approach: A Pilot Study.
    Baselice S; Castaldo R; Giannatiempo R; Casaretta G; Franzese M; Salvatore M; Mirabelli P
    Cancer Control; 2021; 28():10732748211048612. PubMed ID: 34620015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical learning confirms the diagnostic significance of the anemia panel in breast cancer.
    Biljan M; Dmitrović B; Kristek J; Šimundić AM; Mandić S; Šerić V; Margaretić D; Debeljak Ž
    Clin Chem Lab Med; 2012; 50(9):1671-8. PubMed ID: 23104837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
    Kulasingam V; Zheng Y; Soosaipillai A; Leon AE; Gion M; Diamandis EP
    Int J Cancer; 2009 Jul; 125(1):9-14. PubMed ID: 19322904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward standardized high-throughput serum diagnostics: multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer.
    Bünger S; Haug U; Kelly FM; Klempt-Giessing K; Cartwright A; Posorski N; Dibbelt L; Fitzgerald SP; Bruch HP; Roblick UJ; von Eggeling F; Brenner H; Habermann JK;
    J Biomol Screen; 2011 Oct; 16(9):1018-26. PubMed ID: 21807963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.